Gencove inks $3 mln in Spero Ventures-led round


Gencove, a low-pass genome sequencing platform, has secured $3 million in funding. Spero Ventures led the round with participation from Alexandria Venture Investments, Burst Capital, Third Kind Venture Capital and Version One Ventures. In addition to the funding, Shripriya Mahesh, a partner at Spero, will join Gencove’s board of directors.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!